GlycoMimetics Inc.

NASDAQ: GLYC · Real-Time Price · USD
15.71
-0.44 (-2.72%)
At close: Jul 02, 2025, 3:58 PM

GlycoMimetics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
54.09K 54.09K 54.09K 10K 10K 10K 10K 75.00 75.00 75.08K 75.08K 93K 179.56K 104.7K 1.16M 1.31M 2.22M 2.22M
Cost of Revenue
8.13K 8.13K 8.13K 31.43K 293.23K 559.1K 822.06K 1.06M 1.04M 1.04M 1.03M 789.57K 533.54K 275.1K 16.98K n/a n/a n/a
Gross Profit
18.91K 18.91K 18.91K -21.43K -283.23K -549.1K -812.06K -1.06M -1.04M -961.92K -957.08K -696.57K -353.98K -170.4K 1.14M 1.31M 2.22M 2.22M
Operating Income
-42M -31.32M -40.04M -42.3M -40.88M -39.45M -39.28M -40.31M -39.26M -43.68M -47.4M -54.21M -62.78M -63.83M -63.45M -61.59M -57.98M -57.68M
Interest Income
662.77K 612.05K 935.27K 1.34M 1.76M 2.17M 2.38M 2.24M 1.87M 1.29M 714.52K 340.33K 101.36K 20.99K 19.77K 21.3K 21.44K 42.92K
Pretax Income
-19.39M -29.49M -37.88M -39.73M -39.11M -37.28M -36.9M -38.07M -37.39M -42.4M -46.69M -53.87M -62.68M -63.81M -63.43M -61.57M -57.96M -57.64M
Net Income
-19.39M -29.49M -37.88M -39.74M -39.11M -37.28M -36.32M -56.45M -55.53M -60.45M -65.32M -53.53M -62.58M -63.8M -63.43M -61.57M -57.96M -57.64M
Selling & General & Admin
20.42M 15.54M 18.25M 17.48M 18M 18.78M 19.21M 19.63M 18.96M 19.55M 19.09M 18.9M 19.2M 17.98M 17.11M 16.58M 16.49M 16.49M
Research & Development
14.04M 8.25M 14.26M 19.32M 5.31B 5.31B 5.31B 5.31B 20.31M 24.21M 28.39M 35.4M 43.75M 45.95M 47.49M 46.32M 43.7M 43.41M
Other Expenses
7.53M 7.53M 7.53M 5.51M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
42M 31.32M 40.04M 42.31M 40.89M 39.46M 39.28M 40.31M 39.26M 43.76M 47.48M 54.3M 62.96M 63.93M 64.61M 62.89M 60.2M 59.9M
Interest Expense
-1.07M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
143.00 183.00 183.00 183.00 40.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
20.97M 31.32M 40.04M 42.31M 40.89M 39.46M 39.28M 40.31M 39.26M 43.76M 47.48M 54.3M 62.96M 63.93M 64.61M 62.89M 60.2M 59.9M
Income Tax Expense
n/a n/a n/a n/a n/a n/a -581.36K 18.38M 18.14M 18.05M 18.63M -336.55K -93.05K -6.78K 404.00 1.17K 324.00 -443
Shares Outstanding (Basic)
3.86B 64.52M 64.48M 64.48M 64.48M 64.46M 64.39M 64.35M 64.28M 60.35M 52.96M 52.42M 52.41M 52.33M 52.01M 51.56M 51.54M 50.7M
Shares Outstanding (Diluted)
3.86B 64.52M 64.48M 64.48M 64.48M 64.46M 64.39M 64.35M 64.28M 60.35M 52.96M 52.42M 52.41M 52.33M 52.01M 51.56M 51.54M 50.7M
EPS (Basic)
-4.93K -0.46 -0.59 -0.62 -0.61 -0.58 -0.57 -0.98 -1 -1.12 -1.24 -1.02 -1.2 -1.23 -1.23 -1.23 -1.18 -1.22
EPS (Diluted)
-4.93K -0.46 -0.59 -0.62 -0.61 -0.58 -0.57 -0.98 -1 -1.12 -1.24 -1.02 -1.2 -1.23 -1.23 -1.22 -1.17 -1.21
EBITDA
-34.46M -23.77M -32.47M -36.73M -40.78M -39.32M -39.12M -40.13M -39.08M -43.49M -47.2M -53.98M -62.53M -63.57M -63.18M -61.32M -57.71M -57.41M
EBIT
-13.43M -23.79M -32.51M -36.78M -40.88M -39.45M -39.27M -40.31M -39.26M -43.68M -47.4M -54.21M -62.78M -63.83M -63.45M -61.59M -57.98M -57.68M
Depreciation & Amortization
-27.04K -14.62K n/a 58.47K 93.09K 124.08K 372.42K 608.69K 821.97K 1.04M 1.03M 1.03M 1.03M 1.02M 1.01M 826.27K 635.98K 451.24K